Investor FAQs

Investor FAQs

Show all

4150 Ste-Catherine Street West, Suite 550
Montreal, QC H3Z 2Y5
Clementia Pharmaceuticals Inc. was incorporated under the Canada Business Corporations Act in November, 2010.
Clementia’s shares of common stock first started trading on the NASDAQ Global Select Market on August 2, 2017.
Clementia's fiscal year-end is December 31st.
Clementia Pharmaceuticals' common stock is traded on the NASDAQ Global Select Market under the symbol "CMTA".
Currently, Clementia Pharmaceuticals does not pay a dividend or offer a dividend reinvestment program.
The Company's transfer agent is Computershare. You can contact Computershare via their website: Written requests by regular mail can be made to:

Computershare Investor Services
1500 Robert-Bourassa Blvd, 7th Floor
Montreal, Qc, H3A 3S8 Canada

Computershare Investor Services
100 University Ave., 8th Floor, North Tower
Toronto, ON, M5J 2Y1 Canada

Computershare Investor Services
P.O. Box 43078
Providence, RI 02940-3078 USA

Telephone inquiries: 1-800-564-6253 (toll free in Canada and the United States) between the hours of 8:30 a.m. and 8:00 p.m. Eastern Time or 514-982-7555 (international direct call) Monday to Friday Email: (please include a reference to "Clementia Pharmaceuticals Inc." or "CMTA")
KPMG LLP is our independent registered public accounting firm and is located in Montreal, Canada.
Please visit the "Investors" section of our website and choose the "Email Alerts" button to be added to the Clementia Pharmaceuticals distribution list.
Quarterly reports on Form 6-K and annual reports on Form 20-F, as well as other SEC filings, can be accessed in the “Investors” section of our website by clicking on “Financials”, or directly from the SEC at
For investor related questions please send an email to